Summary: We predict the extensive variation of Omicron will reduce the effectiveness of Spike-based vaccines, and substantially reduce the effectiveness of RBD-based vaccines and antibody therapeutics (other than GSK sotrovimab), yet have little impact on RaDVaC vaccines.
Unfortunately radvac won’t be valid when it comes to vaxpass type policies.
https://radvac.org/press-release/
Summary: We predict the extensive variation of Omicron will reduce the effectiveness of Spike-based vaccines, and substantially reduce the effectiveness of RBD-based vaccines and antibody therapeutics (other than GSK sotrovimab), yet have little impact on RaDVaC vaccines.
It’s possible to take RaDVaC for the actual protection and then take the offiically recommended vaccine to get your vaxpass.